SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as escalating Middle East tensions and significant disruptions to the Strait of Hormuz drive oil prices to multi-year highs with historic weekly gains. Traders are fiercely debating whether this represents a sustainable "plumbing break" or an overextended "fear trade" ripe for a pullback, amidst discussions of potential US administration interventions to stabilize the market.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Community excitement for Capricor Therapeutics is surging, driven by news of a key FDA official's departure, with many believing this removes a significant hurdle for Deramiocel's approval for Duchenne Muscular Dystrophy and could trigger a substantial short squeeze ahead of upcoming Phase 3 data presentation.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. (BNAI) is trending after completing an AI licensing partnership in Africa, which, combined with its low float and extremely high cost-to-borrow, is fueling intense short squeeze speculation among traders. The community is actively discussing strong buy-side pressure and the stock's resilience amidst a broader red market, with many holding for significant upside.

uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, Netherlands.

uniQure N.V.

uniQure NV

uniQure (QURE) is trending as the community speculates that the impending departure of a key FDA official could lead to a more favorable regulatory path for its Huntington's disease gene therapy, AMT-130, after prior setbacks. This has sparked intense debate between those anticipating accelerated approval for gene therapies and bears who remain skeptical of the underlying drug data and the sustainability of the rally.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending with surging volume, fueled by intense short-covering and bullish community sentiment. Investors are optimistic about a significant re-rating, citing recent analyst upgrades, M&A buzz in the oncology sector, and anticipated data readouts for its promising TIL therapy platform.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences (SLS) is gaining significant attention after its CEO highlighted potential "curative outcomes" for AML with GPS and SLS009, reinforcing expectations of extended patient survival in the REGAL trial and fueling widespread community speculation of an impending buyout and substantial short squeeze.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing extreme volatility, drawing polarized community sentiment between dip-buyers confident in long-term AI demand and short-sellers citing geopolitical concerns and the ETF's repeated failure to break key resistance. The leveraged semiconductor fund is seeing rapid swings, driven by mixed reactions to sector earnings and broader market uncertainty.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending as the anticipated departure of a key FDA official fuels community speculation for a significantly softened regulatory landscape for gene therapies, with many expecting SRPT to follow recent rallies in comparable biotechs ahead of upcoming pivotal DM1 and FSHD data readouts.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum is drawing significant attention following its S&P 500 inclusion, which is expected to drive institutional buying, and a substantial $2 billion investment from NVIDIA to secure advanced optical technology for AI data centers. While many are bullish on LITE's pivotal role in AI infrastructure, a segment of the community debates its rapid, "parabolic" valuation and the potential for a sharp correction.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending after the FDA accepted its resubmitted BLA for RP1 in advanced melanoma, setting an April 10, 2026 PDUFA date and reigniting investor confidence following previous regulatory hurdles. The community is actively discussing the potential for approval and significant analyst price target upgrades, while some express caution regarding the long timeline and potential for dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Highwoods Properties, Inc. (NYSE:HIW) Given Consensus Recommendation of "Hold" by Brokerages

Highwoods Properties, Inc. (NYSE:HIW - Get Free Report) has received an average rating of "Hold" from the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. One...

JPMorgan Chase & Co. Purchases 61,443 Shares of Highwoods Properties, Inc. $HIW

JPMorgan Chase & Co. lifted its position in Highwoods Properties, Inc. (NYSE:HIW - Free Report) by 8.6% in the third quarter, according to its most recent filing with the Securities and Exchange...

Vanguard Group Inc. Purchases 295,289 Shares of Highwoods Properties, Inc. $HIW

Vanguard Group Inc. raised its position in Highwoods Properties, Inc. (NYSE:HIW - Free Report) by 1.8% during the third quarter, according to the company in its most recent 13F filing with the...

Aew Capital Management L P Grows Stake in Highwoods Properties, Inc. $HIW

Aew Capital Management L P lifted its stake in shares of Highwoods Properties, Inc. (NYSE:HIW - Free Report) by 95.4% in the 3rd quarter, according to the company in its most recent 13F filing with...

Wall Street Zen Downgrades Highwoods Properties (NYSE:HIW) to Sell

Wall Street Zen lowered shares of Highwoods Properties from a "hold" rating to a "sell" rating in a research report on Saturday...

Highwoods Properties (NYSE:HIW) Price Target Lowered to $24.00 at Citigroup

Citigroup decreased their target price on Highwoods Properties from $30.00 to $24.00 and set a "neutral" rating for the company in a research report on Wednesday...

LSV Asset Management Has $35.50 Million Stock Holdings in Highwoods Properties, Inc. $HIW

LSV Asset Management grew its stake in shares of Highwoods Properties, Inc. (NYSE:HIW - Free Report) by 11.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the...

Caprock Group LLC Invests $1.86 Million in Highwoods Properties, Inc. $HIW

Caprock Group LLC acquired a new stake in shares of Highwoods Properties, Inc. (NYSE:HIW - Free Report) during the third quarter, according to the company in its most recent disclosure with the...

Highwoods Properties Q4 Earnings Call Highlights

Highwoods Properties (NYSE:HIW) outlined a more constructive view of Sun Belt office fundamentals and detailed a year of active portfolio repositioning during its fourth-quarter 2025 earnings call...

Highwoods Properties (NYSE:HIW) Reaches New 1-Year Low on Disappointing Earnings

Highwoods Properties (NYSE:HIW) Hits New 52-Week Low on Disappointing Earnings...

Highwoods Properties, Inc. is a real estate investment trust, which owns, develops, acquires, leases and manages properties. The firm also engages in the operation, acquisition, and development of rental office properties. It operates through the following geographical segments: Atlanta, Charlotte, Nashville, Orlando, Raleigh, Richmond, and Tampa. The company was founded by Ronald P. Gibson in 1994 and is headquartered in Raleigh, NC.

Current Price	$22.14
Prev Close	$22.97
Open	$22.72
Dividend Yield	7.75%
50-Day Moving Average	$25.21
Beta	0.93
Avg. Volume	1.66M
PE Ratio	15.86

52-Week High	$32.76
52-Week Low	$21.56
Market Capitalization	$2.53B
EPS (Annual)	$1.42
Price to Book	1.07
Revenue Per Employee	$2.58M

HIW
Highwoods Properties, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HIW News

HIWHighwoods Properties, Inc.